Concepedia

Joseph E. Grossman

JE

Statistics

Publications

14

Citations

533

H-Index

11

Active since

1994

Affiliations

Agenus (United States)(Current)

Beth Israel Deaconess Medical Center

The University of Texas Health Science Center at San Antonio

University of Colorado Denver

University of Colorado Cancer Center

Joseph E. Grossman is an author at Agenus (United States) specializing in medicine, immunotherapy, and immunology.

ORCID

Top concepts

Publications per year

1994–2025

14

Publications

14

PDX-derived organoids model in vivo drug response and secrete biomarkers

Ling Huang, Bruno Bockorny, Indranil Paul et al. · JCI Insight · 2020 · 125 citations · Full text

Empirical identification and validation of tumor-targeting T cell receptors from circulation using autologous pancreatic tumor organoids

Qingda Meng, Shanshan Xie, G. Kenneth Gray et al. · Journal for ImmunoTherapy of Cancer · 2021 · 81 citations · Full text

Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial

Andrea J. Bullock, Benjamin L. Schlechter, Marwan Fakih et al. · Nature Medicine · 2024 · 79 citations · Full text

Results from a phase 1a/1b study of botensilimab (BOT), a novel innate/adaptive immune activator, plus balstilimab (BAL; anti-PD-1 antibody) in metastatic heavily pretreated microsatellite stable colorectal cancer (MSS CRC).

Anthony B. El-Khoueiry, Marwan Fakih, Michael S. Gordon et al. · Journal of Clinical Oncology · 2023 · 54 citations

, , +23

LBA O-9 Botensilimab, a novel innate/adaptive immune activator, plus balstilimab (anti-PD-1) for metastatic heavily pretreated microsatellite stable colorectal cancer

Andrea J. Bullock, Joseph E. Grossman, Marwan Fakih et al. · Annals of Oncology · 2022 · 48 citations

, , +6

1–5 of 14